# Pharma R&D Data Engineering Market Strategy

**Status:** Draft
**Parent:** STRATEGY.md Section 2 (Target Market → Pharma R&D)
**Priority:** #2 (Highest LTV)
**Version:** 0.1
**Date:** January 20, 2026

---

## 1. Executive Summary

This substrategy details how Casparian Flow captures the Pharma/Biotech R&D data engineering market by positioning as **"FDA-Compliant Instrument Data Ingestion"**.

**Core Insight:** Pharma R&D teams have terabytes of XML, JSON, and binary files from Mass Spectrometers and HPLC machines sitting on shared lab network drives. They must prove to the FDA that data in their warehouse matches the raw files on disk.

**Why Pharma Is #2 (Highest LTV):**

| Factor | Pharma R&D | DFIR (#1 contrast) |
|--------|------------|-------------------|
| **The Data** | Instrument files (XML, binary) on lab network drives | Disk images, system logs on evidence servers |
| **Writes Python?** | YES (ETL scripts) | YES (artifact parsers) |
| **Audit Trail** | **FDA REQUIRED** (21 CFR Part 11) | **LEGALLY REQUIRED** (chain of custody) |
| **Why They Pay** | Compliance + traceability | Speed + liability |
| **Sales Cycle** | Slower (enterprise) | Fast (boutiques) |
| **LTV** | **HIGHEST** (sticky forever) | High (per-engagement) |
| **Urgency** | Medium (nightly batch) | EXTREME (active breach) |

**The Pitch:**
> *"Automated, compliant ingestion for instrument data. 21 CFR Part 11 ready out of the box."*

**Why After DFIR:** Slower sales cycle (enterprise), but once in their pipeline, you never leave. DFIR first for cash flow validation; Pharma for enterprise growth.

---

## 2. Market Overview

### 2.1 Pharma/Biotech Industry Size

| Metric | Value | Source |
|--------|-------|--------|
| Global pharma R&D spend | ~$250B/year | PhRMA |
| Biotech R&D spend | ~$100B/year | BIO |
| Lab informatics market | ~$3B (2024) | Various |
| LIMS/ELN market | ~$2B | Gartner |
| Instrument data management | ~$500M+ | Emerging |

### 2.2 The Data Problem

Every pharma R&D lab generates massive amounts of instrument data:

```
Lab Network Drive (typical)
├── mass_spec_01/
│   ├── 2024/
│   │   ├── experiment_001.raw     (proprietary binary)
│   │   ├── experiment_001.xml     (metadata)
│   │   └── ...
│   └── 2025/
├── hplc_02/
│   ├── runs/
│   │   ├── run_20260120_001.txt   (CSV-like)
│   │   └── ...
├── plate_reader/
│   ├── assays/
│   │   └── assay_results.xlsx     (Excel)
└── sequencer/
    └── fastq/                      (genomics)
```

**The Problem:** This data must flow to:
1. **Scientists** (for analysis in Python/R)
2. **Data Warehouse** (Snowflake/Databricks for ML)
3. **Regulatory Submission** (FDA requires traceability)

### 2.3 FDA 21 CFR Part 11 Requirements

**21 CFR Part 11** is the FDA regulation for electronic records and signatures. Key requirements:

| Requirement | What It Means | Casparian Feature |
|-------------|---------------|-------------------|
| **Audit Trail** | Must track who did what, when | **Lineage columns** (`_cf_processed_at`, `_cf_parser_version`) |
| **Data Integrity** | Must prove data wasn't altered | **Source Hash** (`_cf_source_hash`) |
| **Validation** | Must validate software | **Schema Contracts** (deterministic, testable) |
| **Access Control** | Must control who can modify | Local-first (no cloud exposure) |

**Key Insight:** Casparian's **Source Hash** proves the warehouse data matches the original file. This is a compliance feature, not just nice-to-have.

### 2.4 Current State of Lab Data Engineering

| Approach | Prevalence | Problem |
|----------|------------|---------|
| **Manual Excel** | 40% | No automation, error-prone |
| **Custom Python scripts** | 35% | No governance, no validation |
| **LIMS integration** | 15% | Limited to LIMS-supported instruments |
| **Enterprise ETL (Informatica)** | 10% | Expensive, overkill, doesn't understand instrument formats |

**The Gap:** No tool specifically addresses "instrument files on network drive → validated warehouse" with 21 CFR Part 11 compliance.

---

## 3. Target Personas

### 3.1 Primary: Lab Data Engineer

| Attribute | Description |
|-----------|-------------|
| **Role** | Data Engineer, Lab Informatics Engineer, Scientific Data Analyst |
| **Technical skill** | **Python, SQL, pandas**; comfortable with ETL |
| **Pain** | Writing scripts to parse instrument files; no governance; compliance burden |
| **Goal** | Automate instrument data ingestion with audit trail |
| **Buying power** | Recommender; team lead can approve $10K-50K |

**Current Workflow (painful):**
1. Instrument generates files on network drive
2. Engineer writes Python script to parse vendor format
3. Script runs in cron, pushes to Snowflake
4. QA asks: "Can you prove this matches the source file?"
5. Engineer: "...let me add some logging..."
6. Audit: "Where's the validation documentation?"
7. Engineer spends weeks on compliance documentation

**Casparian Workflow:**
1. `casparian scan /lab/mass_spec --tag mass_spec_data`
2. `casparian run mass_spec_parser.py --sink snowflake://...`
3. Every row has `_cf_source_hash` linking to original file
4. Schema contracts document expected output
5. Compliance officer: "Show me the audit trail" → Done

### 3.2 Secondary: Lab Informatics Manager

| Attribute | Description |
|-----------|-------------|
| **Role** | Director of Lab Informatics, Head of Scientific Computing |
| **Technical skill** | Medium-High; manages technical team |
| **Pain** | Staff turnover = lost institutional knowledge; compliance audits |
| **Goal** | Standardized, validated data pipelines |
| **Buying power** | Department budget; can approve $50K-200K/year |

### 3.3 Tertiary: Quality Assurance / Compliance

| Attribute | Description |
|-----------|-------------|
| **Role** | QA Manager, Compliance Officer, Validation Specialist |
| **Technical skill** | Low-Medium |
| **Pain** | Must document everything for FDA; manual validation is costly |
| **Goal** | Auditable, validated data systems |
| **Buying power** | Influences technical decisions; compliance budget |

---

## 4. Competitive Landscape

### 4.1 Lab Informatics Tools

| Product | What It Does | Price | Gap |
|---------|--------------|-------|-----|
| **LabWare LIMS** | Sample management | $100K+/year | Limited instrument integration |
| **Benchling** | ELN + data mgmt | $50K+/year | Focus on biology, not instruments |
| **Dotmatics** | Scientific data platform | Enterprise | Heavy, not file-focused |
| **Tetra Data Platform** | Instrument integration | $200K+/year | Enterprise only |
| **Custom scripts** | ETL | "Free" | No governance, no compliance |

### 4.2 Why These Aren't Enough

| Competitor | Why Casparian Wins |
|------------|-------------------|
| LIMS vendors | Only support their instruments; we handle any format |
| Benchling | Biology focus; we're instrument-agnostic |
| Tetra | Enterprise pricing; we're accessible to mid-size biotech |
| Custom scripts | No audit trail; we're compliance-ready |

### 4.3 The Market Gap

```
┌─────────────────────────────────────────────────────────────────────┐
│                     ENTERPRISE TIER                                  │
│  Tetra, Dotmatics, Informatica ($200K+/year)                        │
│  → Big Pharma, enterprise IT                                        │
└─────────────────────────────────────────────────────────────────────┘
                          ↑
                    MARKET GAP
              (We target this gap)
                          ↓
┌─────────────────────────────────────────────────────────────────────┐
│                     DIY TIER                                         │
│  Python scripts, manual Excel, tribal knowledge                      │
│  → Biotech startups, academic spin-offs, mid-size pharma            │
└─────────────────────────────────────────────────────────────────────┘
```

---

## 5. Why Casparian Fits

### 5.1 Core Platform Features → Pharma Value

| Casparian Feature | Pharma/FDA Value |
|-------------------|------------------|
| **Source Hash** (`_cf_source_hash`) | **21 CFR Part 11**: Prove warehouse data matches original file |
| **Schema Contracts** | **Validation**: Deterministic, documented, testable |
| **Lineage tracking** | **Audit Trail**: What was processed, when, by which parser |
| **Parser versioning** | **Change Control**: Know exactly which version produced output |
| **Local-first** | **Data Security**: Sensitive research data stays on-prem |
| **Quarantine** | **Data Quality**: Bad records isolated, not lost |

### 5.2 The Compliance Story

```
AUDITOR QUESTION                       CASPARIAN ANSWER
────────────────                       ─────────────────
"How do you know this data            "Every row has _cf_source_hash
 matches the original file?"           linking to the original file."

"What processing was done?"           "Parser v2.1.0 ran at 2026-01-20
                                       03:00:00. Full lineage attached."

"Is the software validated?"          "Schema contracts define expected
                                       output. Backtest validates before
                                       production. Deterministic execution."

"Where's the audit trail?"            "Job history, parser versions,
                                       quarantine records all in DB."
```

### 5.3 Why "Source Hash" Is The Killer Feature

For FDA compliance, you must prove **data integrity** - that the data in your warehouse is a true representation of the original file.

**The Source Hash Guarantee:**
```
Original File: mass_spec_001.raw
Source Hash: blake3:abc123...

Every row in warehouse:
| sample_id | intensity | _cf_source_hash      |
|-----------|-----------|----------------------|
| S001      | 45.2      | blake3:abc123...     |
| S002      | 67.8      | blake3:abc123...     |

Auditor can verify: hash(mass_spec_001.raw) == blake3:abc123...
Therefore: warehouse data came from this exact file.
```

---

## 6. Go-to-Market

### 6.1 Positioning

**Primary:** "FDA-compliant instrument data ingestion"

**Secondary:** "21 CFR Part 11 audit trail for your lab data pipelines"

### 6.2 Channels

| Channel | Approach | Timeline |
|---------|----------|----------|
| **Lab informatics communities** | LinkedIn, conferences | Month 6-12 |
| **Biotech LinkedIn** | Direct outreach to Data Engineer titles | Month 6-12 |
| **Lab automation vendors** | Partnership (their instruments, our ingestion) | Month 9-18 |
| **Industry conferences** | Lab Informatics, ISPE, DIA | Year 2 |

### 6.3 Content Strategy

| Content | Purpose | Priority |
|---------|---------|----------|
| "FDA-compliant data pipelines from instruments" | Compliance angle | High |
| "21 CFR Part 11 for data engineers" | Education | High |
| "Mass spec data → Snowflake with audit trail" | Technical demo | Medium |
| Case study: [Biotech] reduced validation time by X% | Social proof | Medium |

### 6.4 Demo Script (90 seconds)

```
[0:00] "Your mass spec generates terabytes of data.
       Here's how to get it to Snowflake with full FDA compliance."

[0:10] *Point Casparian at instrument data*
       $ casparian scan /lab/mass_spec --tag mass_spec_raw

[0:20] "Casparian discovers all instrument files, hashes each one."

[0:30] *Run parser*
       $ casparian run mass_spec_parser.py --sink snowflake://lab_db

[0:45] "Every row in Snowflake has _cf_source_hash linking to the original.
       The auditor can verify the hash matches the file on disk."

[0:55] *Show audit report*
       $ casparian report --compliance

[1:10] "Parser version, processing timestamp, quarantine records.
       21 CFR Part 11 audit trail, automated."

[1:20] "That's compliant instrument data ingestion."
```

---

## 7. Premade Parsers (Starter Kits)

Ship these as **examples** to demonstrate the pattern:

### 7.1 Mass Spectrometry Parser (`mass_spec_parser.py`)

**Input:** Vendor-specific formats (Thermo RAW, Waters, Agilent)

**Output Tables:**

| Table | Description |
|-------|-------------|
| `mass_spec_scans` | Individual MS scans with m/z, intensity |
| `mass_spec_metadata` | Experiment metadata |

**Note:** Vendor formats are proprietary. Partner with conversion tools (ProteoWizard).

### 7.2 HPLC Parser (`hplc_parser.py`)

**Input:** Chromatography data files (Empower, ChemStation)

**Output Tables:**

| Table | Description |
|-------|-------------|
| `hplc_runs` | Run metadata |
| `hplc_peaks` | Detected peaks with retention time, area |

### 7.3 Plate Reader Parser (`plate_reader_parser.py`)

**Input:** Excel exports from plate readers (BMG, Tecan)

**Output Tables:**

| Table | Description |
|-------|-------------|
| `plate_readings` | Well-by-well measurements |
| `plate_metadata` | Experiment metadata |

---

## 8. Pricing

### 8.1 Value Analysis

| Role | Salary | Time on Manual ETL | Value of Automation |
|------|--------|-------------------|---------------------|
| Data Engineer | $150K/year | 50% (ETL + compliance) | $75K/year |
| QA/Validation | $120K/year | 20% (documenting ETL) | $24K/year |

**Additional value:** Audit readiness (avoid $500K+ FDA warning letters), faster drug development.

### 8.2 Pricing Tiers

| Tier | Price | Features | Target |
|------|-------|----------|--------|
| **Team** | $1,000/month | Full platform, 5 users, compliance reports | Mid-size biotech |
| **Department** | $3,000/month | Unlimited users, validation package | Large biotech |
| **Enterprise** | $50K+/year | SSO, dedicated support, on-prem | Big Pharma |

### 8.3 Why Enterprise Pricing Works

Pharma companies spend:
- $50K-500K on LIMS systems
- $200K+ on enterprise data platforms
- $100K+ on validation consulting per system

Casparian at $50K/year is **cheap** for compliant infrastructure.

---

## 9. Success Metrics

### 9.1 Adoption Metrics (Year 1)

| Metric | 6-Month Target | 12-Month Target |
|--------|----------------|-----------------|
| Biotech pilots | 2 | 5 |
| Data Engineers using | 5 | 20 |
| Files processed | 10K | 100K |

### 9.2 Revenue Metrics

| Metric | 6-Month Target | 12-Month Target |
|--------|----------------|-----------------|
| Pharma MRR | $3K | $15K |
| Enterprise contracts | 0 | 2 |
| Annual contract value | - | $50K+ each |

### 9.3 Validation Metrics

| Metric | Target |
|--------|--------|
| "Source hash is valuable" feedback | 3+ pilots |
| Successful FDA audit with Casparian | 1 (Year 2) |
| Validation documentation template | Created and tested |

---

## 10. Risks & Mitigations

| Risk | Severity | Mitigation |
|------|----------|------------|
| Long enterprise sales cycle | High | Start with mid-size biotech; DFIR cash flow first |
| Vendor format complexity | Medium | Partner with conversion tools; focus on common formats |
| FDA software validation requirements | Medium | Create validation template; document deterministic behavior |
| Big vendor enters market | Medium | Speed advantage; focus on flexibility vs. enterprise features |
| Requires domain expertise | Medium | Partner with lab informatics consultants |

---

## 11. References

- [21 CFR Part 11](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-11) - FDA electronic records regulation
- [ISPE GAMP 5](https://ispe.org/publications/guidance-documents/gamp-5-guide-2nd-edition) - Software validation framework
- [ProteoWizard](http://proteowizard.sourceforge.net/) - MS format conversion
- [Lab Informatics Institute](https://www.labinformaticsinstitute.com/) - Community

---

## 12. Revision History

| Date | Version | Changes |
|------|---------|---------|
| 2026-01-20 | 0.1 | Initial draft based on refined strategic evaluation |
